Lung Cancer Excellence Forum

Lung Cancer

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

SPONSORED

Challenges of Biomarker Testing in Non-Small Cell Lung Cancer

In part 1 of this roundtable series featuring thought leaders in lung cancer, our panelists explore biomarker testing, the need for liquid biopsy, and the current challenges and unmet needs in targeted treatment selection. Sponsored by: Daiichi Sankyo.

Videos

Dr Spira Highlights Amivantamab as Promising Treatment in METex14 Mutated NSCLC

09/10/2021

Alexander Spira, MD, PhD, FACP, discusses new evidence supporting the use of the amivantamab in the treatment of patients with NSCLC with MET exon 14 skipping (METex14) mutations, to be presented at the IASLC 2021 World Conference on Lung...

Alexander Spira, MD, PhD, FACP,...

09/10/2021

Oncology

Interview

Dr Kennedy Discusses IMI for Nonpalpable Tumors

09/07/2021

Gregory T. Kennedy, MD, discusses findings from an original investigation on targeted intraoperative molecular imaging for localizing nonpalpable tumors and quantifying resection margin distances.

Gregory T. Kennedy, MD,...

09/07/2021

Oncology

Dr Santos, Dr Raez, Dr Albrecht, Dr Socinski, Dr Heymach

Debates and Roundtables

Expert Roundtable: Are All EGFR-Sensitive Mutations Equal or Should They Be Approached Differently?

07/14/2021

In this virtual roundtable discussion, experts sat down with Oncology Learning Network to discuss EGFR sensitive mutations in patients with lung cancer.

In this virtual roundtable...

07/14/2021

Oncology

Videos

Dr Le Shares Promising Data on Poziotinib for NSCLC With EGFR or HER2 Mutations

04/28/2021

Xiuning Le, MD, PhD, discusses results from the ZENITH20 trial, which showed that twice daily poziotinib improved AEs and retained anti-tumour activity in EGFR+ or HER2+ NSCLC.

Xiuning Le, MD, PhD, discusses...

04/28/2021

Oncology

Debates and Roundtables

The Future Role of Liquid Biopsies in Lung Cancer Detection

10/06/2020

In the second installment of this roundtable discussion, experts sat down with Oncology Learning Network to discuss use of liquid biopsies to detect treatment resistance in lung cancer, areas for growth of the technology, and potential future...

In the second installment of...

10/06/2020

Oncology

Podcasts

Dr Jazieh Highlights the Prevalence of ALK+ NSCLC in the Middle East and North Africa

09/28/2020

Abdul Rahman Jazieh, MD, MPH, discusses a study on the prevalence of ALK+ NSCLC in the Middle East and North Africa and the importance of testing, presented at the ESMO 2020 Virtual Congress.

Abdul Rahman Jazieh, MD, MPH,...

09/28/2020

Oncology